Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
01 2022
Historique:
received: 22 02 2021
accepted: 11 08 2021
pubmed: 24 10 2021
medline: 1 4 2022
entrez: 23 10 2021
Statut: ppublish

Résumé

This prospective, observational study examines associations between 51 urinary metabolites and risk of progression of diabetic nephropathy in individuals with type 1 diabetes by employing an automated NMR metabolomics technique suitable for large-scale urine sample collections. We collected 24-h urine samples for 2670 individuals with type 1 diabetes from the Finnish Diabetic Nephropathy study and measured metabolite concentrations by NMR. Individuals were followed up for 9.0 ± 5.0 years until their first sign of progression of diabetic nephropathy, end-stage kidney disease or study end. Cox regressions were performed on the entire study population (overall progression), on 1999 individuals with normoalbuminuria and 347 individuals with macroalbuminuria at baseline. Seven urinary metabolites were associated with overall progression after adjustment for baseline albuminuria and chronic kidney disease stage (p < 8 × 10 Branched-chain amino acids and other urinary metabolites were associated with the progression of diabetic nephropathy on top of baseline albuminuria and chronic kidney disease. We found differences in associations for overall progression and progression from normo- and macroalbuminuria. These novel discoveries illustrate the utility of analysing urinary metabolites in entire population cohorts.

Identifiants

pubmed: 34686904
doi: 10.1007/s00125-021-05584-3
pii: 10.1007/s00125-021-05584-3
pmc: PMC8660744
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-149

Informations de copyright

© 2021. The Author(s).

Références

Kidney Res Clin Pract. 2019 Dec 31;38(4):414-426
pubmed: 31558011
Diabetologia. 2020 Mar;63(3):636-647
pubmed: 31807796
Biochim Biophys Acta. 2010 Jun;1798(6):1164-71
pubmed: 20211600
Diabetes. 2004 Sep;53(9):2449-54
pubmed: 15331558
Int J Epidemiol. 2019 Jun 1;48(3):978-993
pubmed: 30689875
Sci Rep. 2018 Aug 17;8(1):12408
pubmed: 30120300
PLoS One. 2013 Aug 02;8(8):e71199
pubmed: 23936492
Nephron. 2017;136(4):287-291
pubmed: 27978513
Diabetes Care. 2017 Dec;40(12):1779-1786
pubmed: 29046328
Sci Rep. 2018 Sep 14;8(1):13853
pubmed: 30217994
Mol Pharmacol. 1985 Jun;27(6):644-51
pubmed: 2860559
Nat Genet. 2020 Feb;52(2):167-176
pubmed: 31959995
Diabetes Care. 2017 Mar;40(3):383-390
pubmed: 28087576
Diabetologia. 2018 May;61(5):996-1011
pubmed: 29520581
Nature. 2008 May 15;453(7193):396-400
pubmed: 18425110
Metabolomics. 2019 Dec 10;16(1):5
pubmed: 31823035
Nutrients. 2019 Jun 16;11(6):
pubmed: 31208147
Ann Transl Med. 2018 Apr;6(7):121
pubmed: 29955581
J Am Soc Nephrol. 2016 Apr;27(4):1175-88
pubmed: 26449609
Diabetologia. 2019 Dec;62(12):2298-2309
pubmed: 31584131
Am J Physiol Endocrinol Metab. 2000 May;278(5):E877-84
pubmed: 10780944
Kidney Int. 2014 May;85(5):1214-24
pubmed: 24429397
Life Sci. 2019 Nov 15;237:116950
pubmed: 31605709
Nephrol Dial Transplant. 1998 Dec;13(12):3079-83
pubmed: 9870469
J Proteome Res. 2012 Mar 2;11(3):1782-90
pubmed: 22204613
Kidney Int. 2005 Nov;68(5):2281-7
pubmed: 16221230
Physiol Rev. 2008 Jan;88(1):249-86
pubmed: 18195088
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Diabetes Care. 2020 Aug;43(8):1885-1892
pubmed: 32444456
Kidney Int. 2017 Jun;91(6):1426-1435
pubmed: 28302371
Kidney Int. 2010 Apr;77(7):617-23
pubmed: 20072112
Nat Rev Nephrol. 2017 Oct;13(10):629-646
pubmed: 28804120
Kidney Int. 2014 Jan;85(1):103-11
pubmed: 24048377
Int J Obes (Lond). 2010 Jun;34(6):1095-8
pubmed: 20212498
Curr Opin Clin Nutr Metab Care. 2021 Jan;24(1):10-17
pubmed: 33323714
N Engl J Med. 1969 Oct 9;281(15):811-6
pubmed: 5809519
Mol Metab. 2019 Dec;30:250-263
pubmed: 31767176
Diabet Med. 2014 Sep;31(9):1138-47
pubmed: 24661264
Diabetes Care. 2005 Aug;28(8):2019-24
pubmed: 16043748
FEBS J. 2022 Feb;289(4):901-921
pubmed: 33630415
J Nutr. 1950 Jan;40(1):145-58
pubmed: 15403531
J Am Soc Nephrol. 2013 Nov;24(11):1901-12
pubmed: 23949796
Sci Rep. 2017 Dec 12;7(1):17400
pubmed: 29234020
BMC Nephrol. 2017 Mar 30;18(1):112
pubmed: 28359252
Diabetes Ther. 2018 Feb;9(1):349-361
pubmed: 29139080
Kidney Blood Press Res. 2019;44(2):245-263
pubmed: 31071709

Auteurs

Stefan Mutter (S)

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Erkka Valo (E)

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Viljami Aittomäki (V)

Nightingale Health Ltd, Helsinki, Finland.

Kristian Nybo (K)

Nightingale Health Ltd, Helsinki, Finland.

Lassi Raivonen (L)

Nightingale Health Ltd, Helsinki, Finland.

Lena M Thorn (LM)

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Carol Forsblom (C)

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Niina Sandholm (N)

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

Peter Würtz (P)

Nightingale Health Ltd, Helsinki, Finland.

Per-Henrik Groop (PH)

Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland. per-henrik.groop@helsinki.fi.
Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. per-henrik.groop@helsinki.fi.
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland. per-henrik.groop@helsinki.fi.
Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia. per-henrik.groop@helsinki.fi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH